Cure My Disease

Don't miss your cure!

Log in / Sign up

Xeroderma pigmentosum group B

MONDO:0012531

Any xeroderma pigmentosum in which the cause of the disease is a mutation in the ERCC3 gene.

Also known as: ERCC3 xeroderma pigmentosum, XP, Group B, XP-B, XPB, XPBC, xeroderma pigmentosum caused by mutation in ERCC3, xeroderma pigmentosum group B, xeroderma pigmentosum group type B

3 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Broader categories

Disease (680) Metabolic disease (233) Hereditary disease (176) Skin disorder (132) Inborn errors of metabolism (45) Syndromic disease (25) Human disease (14) DNA repair disease (13) Hereditary skin disorder (6) Xeroderma pigmentosum (4)

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New drug combo targets Hard-to-Treat cancers in early trial

Disease control Recruiting now

This study tests a new drug called AZD4956, alone or with other cancer drugs, in people with advanced or spreading solid tumors that have a specific DNA repair defect (HRR deficiency). The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. …

Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Aug 13, 2026 00:00 UTC